Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 32 holding rows worth $2,036,804,000.

Accession
0001654954-18-005283
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 32 entries on the cover page, a total value of $2,036,804,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,036,804,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SHIRE PLC82481R106COMMON STOCK-FO1,100,000$164,329,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM1,500,000$159,390,000thousands by filing date
ALLERGAN PLCG0177J108SHS850,000$143,047,000thousands by filing date
BIOGEN INC COM09062X103Stock515,000$141,017,000thousands by filing date
HCA Healthcare Inc40412C101COM1,250,000$121,250,000thousands by filing date
ENVISION HEALTHCARE CORP29414D100COM2,850,000$109,526,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock4,250,000$103,063,000thousands by filing date
TESARO INC881569107COM1,725,000$98,567,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock780,000$92,360,000thousands by filing date
Bristol-Myers Squibb Company110122108COM1,250,000$79,063,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM2,458,100$76,914,000thousands by filing date
MEDICINES CO584688105COM2,000,000$65,880,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock1,616,690$63,051,000thousands by filing date
NUVASIVE INC670704105COM1,200,000$62,652,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR1,500,000$58,605,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM1,200,000$57,960,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM2,650,000$53,398,000thousands by filing date
MYLAN NVN59465109SHS EURO1,250,000$51,463,000thousands by filing date
MYRIAD GENETICS INC62855J104COM1,500,000$44,325,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM6,500,000$43,615,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM825,000$43,560,000thousands by filing date
ENDOLOGIX INC29266S106COM9,300,000$39,339,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock400,000$33,336,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK1,236,360$27,113,000thousands by filing date
K2M GROUP HLDGS INC48273J107COM1,349,323$25,570,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM1,500,000$23,880,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS815,000$16,170,000thousands by filing date
ENDO INTL PLCG30401106SHS2,500,000$14,850,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM1,000,000$9,560,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock250,000$9,178,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM135,300$2,456,000thousands by filing date
SURGERY PARTNERS INC86881A100COM135,084$2,317,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001654954-18-005283this filing2018-05-15acceptance time not in the bulk data set